Abstract:Purpose: Accumulating evidence has shown that dysregulation of microRNA-191 (miR-191) is closely associated with tumorigenesis and progression in a wide range of cancers. This study aimed to explore the potential role of miR-191 in esophageal squamous cell carcinoma (ESCC). Materials and Methods: miR-191 expression was assessed in 93 ESCC tissue specimens by real-time polymerase chain reaction, and survival analysis was performed via Kaplan-Meier and Cox regression analyses. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl2- H-tetrazolium bromide, plate colony-forming, BrdU, and Transwell assays were conducted to observe the effect of miR-191 on ESCC proliferation and invasion. Luciferase reporter and western blot assays were taken to identify target genes of miR-191. Results: miR-191 was overexpressed in 93 cases of ESCC, compared with adjacent normal tissues, and miR-191 expression was significantly related to differentiation, depth of invasion, TNM stage, lymph node metastasis, and distant metastasis of tumor. Kaplan-Meier and Cox regression analyses demonstrated that overexpression of miR-191 was an independent and significant predictor of ESCC prognosis. Both gain-of-function and loss-of-function experiments showed that miR-191 promoted ESCC cell proliferation and invasion activities in vitro. Early growth response 1 (EGR1), a tumor suppressor, was predicted as a direct target of miR-191. Luciferase reporter and western blot assays proved that miR-191 reduced EGR1 expression by directly binding its 3' untranslated region. Moreover, EGR1 knockdown by siRNA enhanced ESCC cell growth and invasion. Conclusion: Our findings provide specific biological roles of miR-191 in ESCC survival and progression. Targeting the novel miR191/EGR1 axis represents a potential new therapeutic way to block ESCC development.

Mirna-10A Promotes Cancer Cell Proliferation in Oral Squamous Cell Carcinoma by Upregulating GLUT1 and Promoting Glucose Metabolism.

Inhibition of Microrna-218 Promotes Oral Squamous Cell Carcinoma Growth by Targeting GLUT1 to Affect Glucose Metabolism

Downregulation of Microrna 99a in Oral Squamous Cell Carcinomas Contributes to the Growth and Survival of Oral Cancer Cells.

Mirna-99b-3p Functions As A Potential Tumor Suppressor By Targeting Glycogen Synthase Kinase-3 Beta In Oral Squamous Cell Carcinoma Tca-8113 Cells

Mir-522-3p Promotes Osteosarcoma Cell Growth by Regulating Glucose Uptake and GLUT1 Expression

Mirna-101 Acts As a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CX Chemokine Receptor 7.

Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells

Mir-145 Inhibits Oral Squamous Cell Carcinoma (oscc) Cell Growth by Targeting C-Myc and Cdk6

MiR-99a-5p regulates proliferation, migration and invasion abilities of human oral carcinoma cells by targeting NOX4.

Mir‑543 Acts As a Novel Oncogene in Oral Squamous Cell Carcinoma by Targeting CYP3A5.

Overexpression of Mirna-143 Inhibits Colon Cancer Cell Proliferation by Inhibiting Glucose Uptake

MiR-4513 Mediates the Proliferation and Apoptosis of Oral Squamous Cell Carcinoma Cells Via Targeting CXCL17

Overexpression of Mir-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN

Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma

Next-generation Sequencing for Microrna Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.

MicroRNA-10b Promotes Migration and Invasion Through Hoxd10 in Human Gastric Cancer

Low Expression of Mir-Let-7a Promotes Cell Growth and Invasion Through the Regulation of C-Myc in Oral Squamous Cell Carcinoma.

Mirna Expression Profile In Primary Gastric Cancers And Paired Lymplh Node Metastases Indicates That Mir-10a Plays A Role In Metastasis From Primary Gastric Cancer To Lymph Nodes

Mir-107 Targets TRIAP1 to Regulate Oral Squamous Cell Carcinoma Proliferation and Migration.

Retraction Note: MIR600HG Sponges Mir-125A-5p to Regulate Glycometabolism and Cisplatin Resistance of Oral Squamous Cell Carcinoma Cells Via Mediating RNF44.